KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $9.5 million.

  • Chemed's Gains from Investment Securities rose 84893.62% to $2.2 million in Q2 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 127.82%. This contributed to the annual value of $9.5 million for FY2024, which is 104.64% down from last year.
  • According to the latest figures from FY2024, Chemed's Gains from Investment Securities is $9.5 million, which was down 104.64% from $9.6 million recorded in FY2023.
  • Over the past 5 years, Chemed's Gains from Investment Securities peaked at $25.3 million during FY2020, and registered a low of $9.5 million during FY2024.
  • For the 5-year period, Chemed's Gains from Investment Securities averaged around $15.0 million, with its median value being $15.1 million (2021).
  • As far as peak fluctuations go, Chemed's Gains from Investment Securities plummeted by 4026.77% in 2021, and later surged by 318.59% in 2022.
  • Annual analysis of 5 years shows Chemed's Gains from Investment Securities stood at $25.3 million in 2020, then crashed by 40.27% to $15.1 million in 2021, then increased by 3.19% to $15.6 million in 2022, then plummeted by 38.78% to $9.6 million in 2023, then fell by 1.05% to $9.5 million in 2024.
  • Its Gains from Investment Securities stands at $9.5 million for FY2024, versus $9.6 million for FY2023 and $15.6 million for FY2022.